NM_201596.3:c.1054+7C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_201596.3(CACNB2):​c.1054+7C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.184 in 1,565,510 control chromosomes in the GnomAD database, including 29,134 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.20 ( 3200 hom., cov: 32)
Exomes 𝑓: 0.18 ( 25934 hom. )

Consequence

CACNB2
NM_201596.3 splice_region, intron

Scores

2
Splicing: ADA: 0.00004690
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.332

Publications

10 publications found
Variant links:
Genes affected
CACNB2 (HGNC:1402): (calcium voltage-gated channel auxiliary subunit beta 2) This gene encodes a subunit of a voltage-dependent calcium channel protein that is a member of the voltage-gated calcium channel superfamily. The gene product was originally identified as an antigen target in Lambert-Eaton myasthenic syndrome, an autoimmune disorder. Mutations in this gene are associated with Brugada syndrome. Alternatively spliced variants encoding different isoforms have been described. [provided by RefSeq, Feb 2013]
CACNB2 Gene-Disease associations (from GenCC):
  • Brugada syndrome 4
    Inheritance: AD, Unknown Classification: LIMITED, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics, Laboratory for Molecular Medicine
  • Brugada syndrome 1
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • short QT syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BP6
Variant 10-18527704-C-T is Benign according to our data. Variant chr10-18527704-C-T is described in ClinVar as Benign. ClinVar VariationId is 263263.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.286 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNB2NM_201596.3 linkc.1054+7C>T splice_region_variant, intron_variant Intron 10 of 13 ENST00000324631.13 NP_963890.2
CACNB2NM_201590.3 linkc.892+7C>T splice_region_variant, intron_variant Intron 9 of 12 ENST00000377329.10 NP_963884.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNB2ENST00000324631.13 linkc.1054+7C>T splice_region_variant, intron_variant Intron 10 of 13 1 NM_201596.3 ENSP00000320025.8
CACNB2ENST00000377329.10 linkc.892+7C>T splice_region_variant, intron_variant Intron 9 of 12 1 NM_201590.3 ENSP00000366546.4

Frequencies

GnomAD3 genomes
AF:
0.196
AC:
29721
AN:
151958
Hom.:
3197
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.197
Gnomad AMI
AF:
0.156
Gnomad AMR
AF:
0.285
Gnomad ASJ
AF:
0.141
Gnomad EAS
AF:
0.261
Gnomad SAS
AF:
0.299
Gnomad FIN
AF:
0.191
Gnomad MID
AF:
0.123
Gnomad NFE
AF:
0.167
Gnomad OTH
AF:
0.191
GnomAD2 exomes
AF:
0.221
AC:
55255
AN:
249746
AF XY:
0.218
show subpopulations
Gnomad AFR exome
AF:
0.191
Gnomad AMR exome
AF:
0.392
Gnomad ASJ exome
AF:
0.149
Gnomad EAS exome
AF:
0.261
Gnomad FIN exome
AF:
0.196
Gnomad NFE exome
AF:
0.160
Gnomad OTH exome
AF:
0.196
GnomAD4 exome
AF:
0.183
AC:
258839
AN:
1413432
Hom.:
25934
Cov.:
24
AF XY:
0.186
AC XY:
131097
AN XY:
706258
show subpopulations
African (AFR)
AF:
0.193
AC:
6273
AN:
32506
American (AMR)
AF:
0.379
AC:
16908
AN:
44644
Ashkenazi Jewish (ASJ)
AF:
0.149
AC:
3845
AN:
25806
East Asian (EAS)
AF:
0.293
AC:
11589
AN:
39516
South Asian (SAS)
AF:
0.289
AC:
24671
AN:
85418
European-Finnish (FIN)
AF:
0.187
AC:
9772
AN:
52302
Middle Eastern (MID)
AF:
0.121
AC:
689
AN:
5682
European-Non Finnish (NFE)
AF:
0.163
AC:
174679
AN:
1068766
Other (OTH)
AF:
0.177
AC:
10413
AN:
58792
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
9932
19864
29795
39727
49659
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6402
12804
19206
25608
32010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.196
AC:
29747
AN:
152078
Hom.:
3200
Cov.:
32
AF XY:
0.202
AC XY:
14995
AN XY:
74326
show subpopulations
African (AFR)
AF:
0.197
AC:
8156
AN:
41482
American (AMR)
AF:
0.286
AC:
4361
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.141
AC:
488
AN:
3470
East Asian (EAS)
AF:
0.260
AC:
1342
AN:
5162
South Asian (SAS)
AF:
0.299
AC:
1443
AN:
4824
European-Finnish (FIN)
AF:
0.191
AC:
2026
AN:
10584
Middle Eastern (MID)
AF:
0.122
AC:
36
AN:
294
European-Non Finnish (NFE)
AF:
0.167
AC:
11353
AN:
67972
Other (OTH)
AF:
0.189
AC:
400
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1196
2392
3587
4783
5979
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
324
648
972
1296
1620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.175
Hom.:
1871
Bravo
AF:
0.199
Asia WGS
AF:
0.305
AC:
1060
AN:
3478
EpiCase
AF:
0.166
EpiControl
AF:
0.156

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Brugada syndrome 4 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.70
CADD
Benign
13
DANN
Benign
0.70
PhyloP100
0.33
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000047
dbscSNV1_RF
Benign
0.0020
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4314963; hg19: chr10-18816633; COSMIC: COSV56616514; COSMIC: COSV56616514; API